P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for individuals aged 11-50 years with intermediate and poor-risk metastatic germ cell tumours (GCTs) Meeting Abstract
| Authors: | Mak, B.; Tran, B.; Thomas, H.; Pashankar, F. D.; Hansen, A. R.; Feldman, D. R.; Huddart, R. A.; Wheater, M.; Dunwoodie, E.; Mazhar, D.; Lawrence, N. J.; Stevanovic, A. G.; Birtle, A. J.; Oladipo, O.; Wyld, D.; Balagtas, J. M. S.; Stockler, M. R.; Grimison, P. S.; The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) |
| Abstract Title: | P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for individuals aged 11-50 years with intermediate and poor-risk metastatic germ cell tumours (GCTs) |
| Meeting Title: | 2025 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2025 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-10 |
| Language: | English |
| ACCESSION: | WOS:001454740400039 |
| DOI: | 10.1200/JCO.2025.43.5_suppl.TPS653 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS653 -- Source: Wos |
